Evidence map›Paper›PMID 40430773›Full record

ArticlePathogens (Basel, Switzerland)2025

Ex Vivo Drug Susceptibility of

Yudi T Pinilla, Anton Hoffmann, Maxim Viehweg, Nathanaël Saison, Stravensky Terence Boussougou Sambe, Ange Gatien Doumba Ndalembouly, Barclaye Ngossanga, Florence Awamu, Ayola Akim Adegnika, Steffen Borrmann

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yudi T PinillaCentre de Recherches Médicales de Lambaréné, Lambaréné BP 242, Gabon.
Anton HoffmannCentre de Recherches Médicales de Lambaréné, Lambaréné BP 242, Gabon.ORCID 0000-0002-3124-2067
Maxim ViehwegCentre de Recherches Médicales de Lambaréné, Lambaréné BP 242, Gabon.
Nathanaël SaisonCentre de Recherches Médicales de Lambaréné, Lambaréné BP 242, Gabon.
Stravensky Terence Boussougou SambeCentre de Recherches Médicales de Lambaréné, Lambaréné BP 242, Gabon.
Ange Gatien Doumba NdalemboulyCentre de Recherches Médicales de Lambaréné, Lambaréné BP 242, Gabon.
Barclaye NgossangaCentre de Recherches Médicales de Lambaréné, Lambaréné BP 242, Gabon.
Florence AwamuCentre de Recherches Médicales de Lambaréné, Lambaréné BP 242, Gabon.
Ayola Akim AdegnikaCentre de Recherches Médicales de Lambaréné, Lambaréné BP 242, Gabon.ORCID 0000-0003-3197-5946
Steffen BorrmannCentre de Recherches Médicales de Lambaréné, Lambaréné BP 242, Gabon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AntimalarialsMalariaPlasmodium malariaeAdultArtemisininsArtesunateAtovaquoneChloroquineDrug ResistanceGabonHumansInhibitory Concentration 50LumefantrineParasitic Sensitivity TestsAntimalarialsArtemisininsArtesunateAtovaquoneChloroquineLumefantrinedrug susceptibility assayGabonmalariaP. malariae

Identifiers

PMID40430773
PMCPMC12114257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.